| Code | CSB-RA011583MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to BI-765423, designed to specifically target interleukin-11 (IL-11), a member of the IL-6 cytokine family. IL-11 functions as a pro-fibrotic and pro-inflammatory cytokine that signals through the IL-11 receptor alpha chain and gp130 co-receptor, activating downstream JAK/STAT pathways. This cytokine plays a critical role in tissue remodeling and fibrosis across multiple organ systems. Elevated IL-11 expression has been implicated in various pathological conditions, including idiopathic pulmonary fibrosis, cardiac fibrosis, liver cirrhosis, and certain cancers where it promotes tumor progression and metastasis.
BI-765423 is a humanized IgG1 monoclonal antibody developed by Boehringer Ingelheim that neutralizes IL-11 signaling by preventing receptor engagement. This biosimilar antibody serves as a valuable research tool for investigating IL-11-mediated pathways in fibrotic diseases, inflammatory disorders, and cancer biology. It enables researchers to explore the therapeutic potential of IL-11 blockade and elucidate mechanisms underlying tissue fibrosis and disease progression in preclinical models.
There are currently no reviews for this product.